IJ Pharmaceutical Research
Scopus by Title (Ref)
1. Novel esomeprazole magnesium bilayer tablet with magnesium hydroxide: enhanced onset time and bioavailability in beagle dogs
- Kwon T.K. , et al.
3. Management of Patients With Refractory Reflux-Like Symptoms Despite Proton Pump Inhibitor Therapy: Evidence-Based Consensus Statements
- Armstrong D. , et al.
4. Russian Consensus: Standardization of Indications for Surgical Treatment of GERD
- Khatkov I.Y. , et al.
5. A Comprehensive Review of Gastroesophageal Reflux Disease (GERD) Treatment and its Clinical Perspectives
- Mazumder A. , et al.
6. Is the Addition of Sublingual Melatonin to Omeprazole Superior to Omeprazole Alone in the Management of Gastroesophageal Reflux Disease Symptoms: A Clinical Trial
- Malekpour H. , et al.
7. Baclofen as a therapeutic option for gastroesophageal reflux disease: A systematic review of clinical trials
- Arabpour E. , et al.
8. Medical Management of Gastroesophageal Reflux Disease and the Challenges: A Review
- Mazumder A. , et al.
9. The treatment efficacy of adding prokinetics to PPIs for gastroesophageal reflux disease: a meta-analysis
- Xi L. , et al.
10. Buccal buspirone as add–on therapy to omeprazole versus omeprazole in treatment of gastroesophageal reflux diseases (Gerd)
- Abdi S. , et al.
11. Comparison of the effect of omeprazole, pantoprazole, esomeprazole, and lansoprazole on the reduction of symptoms in patients with gastroesophageal reflux disease
- Arezoomandi N. , et al.
12. Proton Pump Inhibitor–Refractory Gastroesophageal Reflux Disease
- Yadlapati R. , et al.
13. Gastroesophageal Reflux Disease
- Yadlapati R. , et al.
14. Comparing the Effect of Psyllium Seed on Gastroesophageal Reflux Disease With Oral Omeprazole in Patients With Functional Constipation
- Hosseini M. , et al.
15. A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease
- Hillman L. , et al.
16. Clinical pharmacology profile of care in Hepatology clinic
- Passos T.R. , et al.
17. Omeprazole-domperidone fixed dose combination vs omeprazole monotherapy: A phase 4, open-label, comparative, parallel randomized controlled study in mild to moderate gastroesophageal reflux disease
- Marakhouski K. , et al.